Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001972362-25-000285
Filing Date
2025-03-12
Accepted
2025-03-12 17:34:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2768
  Complete submission text file 0001972362-25-000285.txt   4214
Mailing Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879
Business Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Subject) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-33137 | Film No.: 25732984
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O EMERGENT BIOSOLUTIONS INC. 400 PROFESSIONAL DR. STE. 400 GAITHERSBURG MD 20879
Business Address
Fowler Neal Franklin (Reporting) CIK: 0001493692 (see all company filings)

Type: 144